@article{3107561,
    title = "No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(Immuno)therapy",
    author = "Baliakas, P. and Mattsson, M. and Hadzidimitriou, A. and Minga, E. and Agathangelidis, A. and Sutton, L.-A. and Scarfo, L. and Davis, Z. and Yan, X.-J. and Plevova, K. and Sandberg, Y. and Vojdeman, F.J. and Tzenou, T. and Chu, C.C. and Veronese, S. and Mansouri, L. and Smedby, K.E. and Giudicelli, V. and Nguyen-Khac, F. and Panagiotidis, P. and Juliusson, G. and Anagnostopoulos, A. and Lefranc, M.-P. and Trentin, L. and Catherwood, M. and Montillo, M. and Niemann, C.U. and Langerak, A.W. and Pospisilova, S. and Stavroyianni, N. and Chiorazzi, N. and Oscier, D. and Jelinek, D.F. and Shanafelt, T. and Darzentas, N. and Belessi, C. and Davi, F. and Ghia, P. and Rosenquist, R. and Stamatopoulos, K.",
    journal = "Haematologica-the hematology journal",
    year = "2018",
    volume = "103",
    number = "4",
    pages = "e158-e161",
    publisher = "Ferrata Storti Foundation",
    doi = "10.3324/haematol.2017.182634",
    keywords = "cyclophosphamide;  fludarabine;  rituximab, adult;  aged;  cancer chemotherapy;  cancer immunotherapy;  chronic lymphatic leukemia;  female;  follow up;  gene deletion;  gene expression;  gene mutation;  human;  immunogenetics;  Letter;  long term survival;  major clinical study;  male;  retrospective study;  chronic lymphatic leukemia;  drug therapy;  immunotherapy;  middle aged;  mortality;  survival rate;  very elderly;  young adult, Adult;  Aged;  Aged, 80 and over;  Drug Therapy;  Female;  Humans;  Immunotherapy;  Leukemia, Lymphocytic, Chronic, B-Cell;  Male;  Middle Aged;  Retrospective Studies;  Survival Rate;  Young Adult"
}